Taking an Investment Position in Novo Nordisk (NVO-NYSE, $35.50) after Two Year Absence.

The global large cap portfolio is purchasing shares of NVO after sitting on the sidelines for the past 2 years.

Posted in Portfolio Model Subscription

Leave a Reply

Recent Comments
    Archives